FDA.reportPublic FDA data

Widaplik 40 MG / 5 MG / 2.5 MG Oral Tablet

RxCUI
2727465
RxNorm name
Widaplik 40 MG / 5 MG / 2.5 MG Oral Tablet
Display name
Widaplik 40 MG / 5 MG / 2.5 MG Oral Tablet
Full name
Widaplik 40 MG / 5 MG / 2.5 MG Oral Tablet
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:11

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
WIDAPLIKTELMISARTAN, AMLODIPINE AND INDAPAMIDEAzurity Pharmaceuticals, Inc.a30ff81d-420b-40ea-83d8-670260a93fff2026-07-03Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2727465

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
a30ff81d-420b-40ea-83d8-670260a93fffWidaplik 40 MG / 5 MG / 2.5 MG Oral Tablet [PSN] · amlodipine 5 MG / indapamide 2.5 MG / telmisartan 40 MG Oral Tablet [Widaplik] [SBD] · Widaplik 40 MG / 5 MG / 2.5 MG Oral Tablet [SY]32These highlights do not include all the information needed to use WIDAPLIK™ safely and effectively. See full prescribing information for WIDAPLIK. WIDAPLIK (telmisartan, amlodipine and indapamide) tablets, for oral use Initial U.S. Approval: 202520260415